Niagen Bioscience (NASDAQ:NAGE – Get Free Report) released its quarterly earnings data on Tuesday. Niagen Bioscience had a net margin of 14.29% and a return on equity of 22.68%. Niagen Bioscience has a one year low of $3.12 and a one year high of $11.29. Finally, Wall Street Zen cut Niagen Bioscience from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. Featured StoriesReceive News & Ratings for Niagen Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Niagen Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.